There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.
The FDA recently issued a warning that a type of medicine used to treat Type 2 diabetes may increase a person's risk for developing bladder cancer.
An expanded access program (EAP) was just opened up for ceratain patients with ovarian cancer to receive niraparib.
Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.
CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.
On January 19, we'll be co-hosting a tweet chat with Oncology Nursing News and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect
A recent study examined the relationship between polycystic ovarian syndrome, long or irregular periods and ovarian cancer risk.